SEC Form 3 · accession 0001144204-17-015444
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joan Martin
Officer — EXECUTIVE VP AND HEAD OF EMEA
Period of report
Mar 7, 2017
Accepted (ET)
Mar 17, 2017 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 40,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $20.91 | holding | — | — | — | — | Mar 19, 2025 | Common Stock | 160,000 | — | D |
| Employee Stock Option (right to buy) | $11.52 | holding | — | — | — | Feb 17, 2017 | Feb 17, 2026 | Common Stock | 28,549 | — | D |
Explanation of responses
- F140% of the options vest on March 19, 2017, and the balance vests in 36 equal monthly installments beginning on April 19, 2017.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney